Amol Soin

TheraVasc, Inc. operates as a pharmaceutical company. It develops treatments for various chronic medical diseases and drugs for unserved vascular disease markets. The company was founded by Anthony Giordano, Christopher Kevil and James Douglas Boudreaux in 2008 and is headquartered in Cleveland, OH.

Soin Neuroscience, Inc. is a biotech company that specializes in non-opioid based pain management therapies. SNI is based in Dayton, OH and has recently started a medical device division, with several neuromodulation technologies in development. SNI is also working on machine learning and AI-based technologies to help augment physician decision making to make precision medicine possible. However, their sacral nerve stimulation device and spinal cord stimulation device are not approved for use in humans and are currently in early testing phases. The private company was founded by Amol Soin, MD, who has been the CEO since incorporation.

Part of JanOne, Inc., Soin Therapeutics LLC is a biotechnology company based in Dayton, OH. The company has developed multiple different drugs to treat several chronic conditions, with its lead product being a novel proprietary formulation of low dose naltrexone to treat complex regional pain syndrome (CRPS). Soin Therapeutics has received an orphan drug designation from the FDA for their lead product and is planning to commence a large national late-stage efficacy trial in 2022 of their lead product in CRPS patients. The company was founded by Amol Soin, who has been the CEO since incorporation. Soin Therapeutics was acquired by JanOne, Inc. on December 28, 2022 for $30 million.

Physician Investment Group LLC provides investment services. The private company is based in Dayton, OH. The company was founded by Amol Soin.

American Society of Interventional Pain Physicians, Inc. is an association that provides ambulatory and pain management services. The private company is based in Paducah.